SCHEMBL31269405

SCHEMBL31269405

Cc1ccnc(Cn2c(-c3ccc(N4CCN5CCC[C@H]5C4)cc3Cl)nc3c(OC4(C)CC4)ncnc32)c1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 1/20 0.38
▸ CNR1 P21554 3/20 0.36
▸ CNR2 P34972 1/20 0.36
▸ CTSS P25774 3/20 0.35
▸ PIK3CD O00329 5/20 0.35
▸ HTR6 P50406 2/20 0.34
▸ KCNH2 Q12809 2/20 0.34
▸ SCN5A Q14524 1/20 0.33
▸ SCN9A Q15858 1/20 0.33
▸ OGG1 O15527 1/20 0.32
▸ HRH4 Q9H3N8 1/20 0.32
▸ FGFR1 P11362 1/20 0.32
▸ FGFR2 P21802 1/20 0.32
▸ FGFR4 P22455 1/20 0.32
▸ FGFR3 P22607 1/20 0.32
▸ KDR P35968 1/20 0.32
▸ ALK Q9UM73 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31268997 0.85 PIK3CD (0.35) LRRK2CNR1PIK3CDKCNH2SCN5A
SCHEMBL31268973 0.84 PIK3CD (0.38) CNR1CNR2PIK3CDKCNH2SCN5A
SCHEMBL31269090 0.84 HTR6 (0.35) CNR1PIK3CDHTR6KCNH2SCN5A
SCHEMBL31269023 0.84 PIK3CD (0.35) LRRK2CNR1PIK3CDKCNH2SCN5A
SCHEMBL31269320 0.83 HTR6 (0.34) CNR1PIK3CDHTR6KCNH2SCN5A
SCHEMBL31268739 0.83 NOTUM (0.39) CNR1CNR2PIK3CD
SCHEMBL31268791 0.83 CNR1 (0.39) LRRK2CNR1CNR2PIK3CDKCNH2
SCHEMBL31269333 0.82 PIK3CD (0.37) CNR1CNR2PIK3CDKCNH2SCN5A
SCHEMBL31269124 0.82 CNR1 (0.33) CNR1CNR2PIK3CDKCNH2SCN5A
SCHEMBL30983779 0.81 KCNH2 (0.36) CNR1PIK3CDKCNH2SCN5ASCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback